|
|
K A Griffin, M M Picken, A K Bidani
J Clin Invest. 1995;
96(2):793
doi:10.1172/JCI118125
Abstract |
Full text
| PDF

H
ypertensive mechanisms are postulated to play a major role in the progressive glomerulosclerosis (GS) after renal mass reduction. But, in contrast to converting enzyme inhibitors, BP reduction by calcium channel blockers, has not provided consistent protection. Radiotelemetric BP monitoring for 7 wk was used to compare nifedipine (N) and enalapril (E) in the rat approximately 5/6 renal ablation model. After the first week, rats received N, E, or no treatment (C). The overall averaged systolic BP in C (173 +/- 7 mmHg) was reduced by both E and N (P < 0.001), but E was more effective (113 +/- 2 vs. 134 +/- 3 mmHg, P < 0.01). GS was prevented by E (2 +/- 1 vs. 26 +/- 5% in C) but not by N (25 +/- 6%). GS correlated well with the overall averaged BP in individual animals of all groups, but the slope of the relationship was significantly steeper in N compared with C+E rats (P < 0.02), suggesting greater pressure transmission to the glomeruli and GS for any given BP. Since autoregulatory mechanisms provide the primary protection against pressure transmission, renal autoregulation was examined at 3 wk in additional rats. Autoregulation was impaired in C rats, was not additionally altered by E, but was completely abolished by N. These data demonstrate the importance of autoregulatory mechanisms in the pathogenesis of hypertensive injury and suggest that calcium channel blockers which adversely affect pressure transmission may not provide protection despite significant BP reduction.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(55)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
L Gabriel Navar, William J Arendshorst, Thomas L Pallone, Edward W Inscho, John D Imig, P Darwin Bell
|
Comprehensive Physiology
|
2011 |
T-Type Ca Channel Blockade as a Determinant of Kidney Protection
Koichi Hayashi, Koichiro Homma, Shu Wakino, Hirobumi Tokuyama, Naoki Sugano, Takao Saruta, Hiroshi Itoh
|
Keio J. Med.
|
2010 |
Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: Studies in sympathectomized rats
Robert A Augustyniak, Maria M Picken, David Leonard, Xin J Zhou, Weiguo Zhang, Ronald G Victor
|
Clinical and Experimental Pharmacology and Physiology
|
2010 |
Treatment of Proteinuria with Lercanidipine Associated with Renin-Angiotensin Axis-Blocking Drugs
N.R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado, J.J. Cubero
|
Ren Fail
|
2010 |
Potential risks of calcium channel blockers in chronic kidney disease
Karen A. Griffin, Anil K. Bidani
|
Curr Cardiol Rep
|
2009 |
Renoprotective effect of calcium channel blockers
Nada Dimkovic, Sinisa Dimkovic
|
Srp Arh Celok Lek
|
2009 |
Therapy in Nephrology & Hypertension
Maarten W. Taal
|
Therapy in Nephrology & Hypertension
|
2008 |
Calcium Antagonists and Renal Failure Progression
Nicolás Roberto Robles
|
Ren Fail
|
2008 |
Calcium antagonists: Do they equally protect against kidney injury?
P Hart, G L Bakris
|
Kidney Int
|
2008 |
Hypertensive nephrosclerosis
Gary S Hill
|
Current Opinion in Nephrology and Hypertension
|
2008 |
|